...
首页> 外文期刊>Eye >The willingness of patients presenting with advanced glaucoma to participate in a trial comparing primary medical vs primary surgical treatment
【24h】

The willingness of patients presenting with advanced glaucoma to participate in a trial comparing primary medical vs primary surgical treatment

机译:患有晚期青光眼的患者愿意参加一项比较初级药物治疗与初级手术治疗的试验的意愿

获取原文
获取原文并翻译 | 示例
           

摘要

Aim The aim of this study is to examine the attitudes of patients, who presented with advanced glaucoma in at least one eye, to participation in a randomised prospective trial comparing primary medical treatment with primary surgical treatment for advanced glaucoma. Methods Patients who had presented with advanced glaucoma (>15 dB loss mean deviation on Humphrey visual field testing) in at least one eye were asked to participate. Five focus groups comprising of 4-8 patients and consisting of 29 patients in total were undertaken. The group interviews were conducted by two experienced qualitative researchers, an ophthalmic clinician was present to clarify technical issues. The focus group discussions were taped and transcribed in full, and analysed through a process of familiarisation, open (inductive) coding, theme generation, theme refinement, and thematic mapping. Results Three overarching themes were identified: (1) the extent of patients' knowledge, (2) anxieties about surgery, and (3) concerns about compromised care due to trial involvement; these themes were further classified into eight sub-themes. Conclusion sPatients willingness to participate in randomised clinical studies is significantly connected to their level of comprehension and insight about the medical condition, its treatment, and the research process; misunderstandings about any of these aspects may act as a significant barrier to trial recruitment. Recruitment rates for future randomised trials may be enhanced by ensuring that patients have full and accurate information about the treatment alternatives, and that uncertainty exists for best patient outcomes between treatment options, and reassuring potential participants that the research process, in particular randomisation, will not compromise clinical care.
机译:目的这项研究的目的是检查至少有一只眼睛患有晚期青光眼的患者对一项随机前瞻性试验的态度,该试验将初级药物治疗与初级手术治疗晚期青光眼进行了比较。方法要求至少有一只眼睛出现晚期青光眼(汉弗莱视野测试中平均损失大于15 dB)的患者参加。进行了五个焦点小组,包括4-8名患者,总共29名患者。小组访谈是由两名经验丰富的定性研究人员进行的,一位眼科临床医师出席了会议,以澄清技术问题。焦点小组的讨论被录音和转录,并通过熟悉,开放(归纳)编码,主题生成,主题细化和主题映射的过程进行分析。结果确定了三个总体主题:(1)患者的知识程度;(2)对手术的焦虑;(3)对由于试验参与而导致的护理不佳的担忧;这些主题进一步分为八个子主题。结论患者参加随机临床研究的意愿与他们对医疗状况,治疗方法和研究过程的理解程度和洞察力密切相关。对以上任何方面的误解都可能成为招募新兵的重大障碍。通过确保患者具有有关治疗选择的完整而准确的信息,并确保各治疗方案之间的最佳患者结果存在不确定性,并向潜在参与者保证研究过程(尤其是随机化)不会保证其准确性,可以提高未来随机试验的招募率。损害临床护理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号